Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea

다국어 초록 (Multilingual Abstract)

Background: Data on the clinical characteristics of pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection are limited. We aimed to evaluate the clinical features and outcomes of children with SARS-CoV-2 infection before and after omicron variant dominance in Korea.
Methods: A multicenter retrospective cohort study was conducted in hospitalized patients aged ≤ 18 years with laboratory-confirmed SARS-CoV-2 infection at five university hospitals in South Korea. The study periods were divided into the delta (from August 23, 2021 to January 2, 2022) and omicron (from January 30 to March 31, 2022).
Results: In total, 612 hospitalized patients were identified (211, delta; 401, omicron). During the omicron and delta periods, the proportions of individuals with serious illness (moderate, severe, and critical severity) were 21.2% and 11.8%, respectively (P = 0.034). Compared with the delta period, the proportions of patients with moderate illness increased significantly in the age groups of 0–4 years (14.2% vs. 3.4%) and 5–11 years (18.6% vs. 4.2%) during the omicron period. During the two periods, the proportions of patients with complex chronic diseases (delta, 16.0% vs. 4.3%, P = 0.040; omicron, 27.1% vs. 12.7%; P = 0.002), respiratory diseases except for asthma (delta, 8.0% vs. 0.0%, P = 0.013; omicron, 9.4% vs. 1.6%; P = 0.001), and neurologic diseases (delta, 28.0% vs. 3.2%, P < 0.001; omicron, 40.0% vs. 5.1%, P < 0.001) were significantly higher in patients with serious illness than in those with nonserious illness. During the delta period, the risk for serious illness was higher among patients with obesity (adjusted odds ratio [aOR], 8.18; 95% confidence interval [CI], 2.80–27.36) and neurologic diseases (aOR, 39.43; 95% CI, 6.90–268.3) and aged 12–18 years (aOR, 3.92; 95% CI, 1.46–10.85). However, the presence of neurologic disease (aOR, 9.80; 95% CI, 4.50–22.57) was the only risk factor for serious illness during the omicron period. During the omicron period, the proportions of patients with croup (11.0% vs. 0.5%) and seizures (13.2% vs. 2.8%) increased significantly compared with the delta period.
Conclusion: Compared with the delta period, the proportions of young children and patients with complex comorbidities were higher during the omicron period in Korea. Patients with complex chronic diseases, especially neurologic diseases, had a high risk of severe coronavirus disease 2019 in the two distinct variant-dominant periods.

참고문헌 (Reference)

1 Iuliano AD, "Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods-United States, December 2020-January 2022" 71 (71): 146-152, 2022

2 Britton PN, "The spectrum and burden of influenza-associated neurological disease in children : combined encephalitis and influenza sentinel site surveillance from Australia, 2013-2015" 65 (65): 653-660, 2017

3 김재현 ; 윤성하 ; 황승식 ; 심정옥 ; 채현욱 ; 이연주 ; 이지혁 ; 김순철 ; 임도희 ; 양세원 ; 오경원 ; 문진수, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects" 대한소아청소년과학회 61 (61): 135-149, 2018

4 Forrest CB, "Severity of acute COVID-19 in children <18 years old March 2020 to December 2021" 149 (149): e2021055765-, 2022

5 Choi Youn Young ; Choi Soo-Han ; Choi Jae Hong ; Kim Dong Hyun ; Lee Joon Kee ; Eun Byung Wook ; Lee Hyunju ; Kim Ye Kyung ; Ahn Bin ; Song Seung Ha ; Yun Ki Wook, "SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021" 대한의학회 37 (37): 1-13, 2022

6 Hui KP, "SARS-CoV-2 omicron variant replication in human bronchus and lung ex vivo" 603 (603): 715-720, 2022

7 Woodruff RC, "Risk factors for severe COVID-19 in children" 149 (149): e2021053418-, 2022

8 Rose EB, "Respiratory syncytial virus-associated hospitalizations in children with neurological disorders, 2006-2015" 10 (10): 951-957, 2021

9 Simon TD, "Pediatric medical complexity algorithm : a new method to stratify children by medical complexity" 133 (133): e1647-e1654, 2014

10 Cloete J, "Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron(B. 1. 1. 529)variant wave in South Africa : a multicentre observational study" 6 (6): 294-302, 2022

11 Solís-García G, "Neurologic complications in children hospitalized with influenza infections : prevalence, risk factors and impact on disease severity" 39 (39): 789-793, 2020

12 Wang L, "Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 years in the US" 176 (176): 811-813, 2022

13 Marks KJ, "Hospitalizations of children and adolescents with laboratory-confirmed COVID-19-COVID-NET, 14 states, July 2021-January 2022" 71 (71): 271-278, 2022

14 Shi DS, "Hospitalizations of children aged 5-11 years with laboratory-confirmed COVID-19-COVID-NET, 14 states, March 2020-February 2022" 71 (71): 574-581, 2022

15 Havers F, "Hospitalizations attributable to respiratory infections among children with neurologic disorders" 170 : 135-141, 2016

16 Marks KJ, "Hospitalization of infants and children aged 0-4 years with laboratory-confirmed COVID-19-COVID-NET, 14 states, March 2020-February 2022" 71 (71): 429-436, 2022

17 Tagarro A, "Features of COVID-19 in children during the omicron wave compared with previous waves in Madrid, Spain" 41 (41): e249-e251, 2022

18 Simon TD, "Development and validation of the pediatric medical complexity algorithm(PMCA)version 3. 0" 18 (18): 577-580, 2018

19 Butt AA, "Coronavirus disease 2019 disease severity in children infected with the omicron variant" 75 (75): e361-e367, 2022

20 Korea Disease Control and Prevention Agency, "Coronavirus disease 2019 (COVID-19), Republic of Korea"

21 Ludvigsson JF, "Convulsions in children with COVID-19 during the omicron wave" 111 (111): 1023-1026, 2022

22 Kim EY, "Community transmission of SARS-CoV-2 omicron variant, South Korea, 2021" 28 (28): 898-900, 2022

23 World Health Organization, "Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern"

24 Murata Y, "Children with croup and SARS-CoV-2 infection during the large outbreak of omicron" 41 (41): e249-, 2022

25 Martin B, "Characteristics, outcomes, and severity risk factors associated with SARS-CoV-2 infection among children in the US National COVID Cohort Collaborative" 5 (5): e2143151-, 2022

26 Brewster RC, "COVID-19-associated croup in children" 149 (149): e2022056492-, 2022

27 Yang S, "COVID-19 outbreak report from January 20, 2020 to January 19, 2022 in the Republic of Korea" 15 (15): 414-426, 2022

28 Price AM, "BNT162b2 protection against the omicron variant in children and adolescents" 386 (386): 1899-1909, 2022

29 Martin B, "Acute upper airway disease in children with the omicron(B. 1. 1. 529)variant of SARS-CoV-2-a report from the US National COVID Cohort Collaborative" 176 (176): 819-821, 2022